nodes	percent_of_prediction	percent_of_DWPC	metapath
Levorphanol—Estradiol—Fulvestrant—breast cancer	0.56	0.73	CrCrCtD
Levorphanol—Estrone—Exemestane—breast cancer	0.207	0.27	CrCrCtD
Levorphanol—Estradiol—GPER1—breast cancer	0.00145	0.194	CrCbGaD
Levorphanol—Estradiol—ESRRA—breast cancer	0.000932	0.125	CrCbGaD
Levorphanol—Estrone—SLCO1B1—breast cancer	0.000379	0.0508	CrCbGaD
Levorphanol—Estradiol—SLCO1B1—breast cancer	0.000287	0.0385	CrCbGaD
Levorphanol—Estrone—ESR2—breast cancer	0.000262	0.0352	CrCbGaD
Levorphanol—Estrone—CYP1B1—breast cancer	0.000239	0.0321	CrCbGaD
Levorphanol—Estrone—SHBG—breast cancer	0.000239	0.0321	CrCbGaD
Levorphanol—Dihydrocodeine—CYP2D6—breast cancer	0.000221	0.0296	CrCbGaD
Levorphanol—Hydromorphone—PTGS1—breast cancer	0.000206	0.0276	CrCbGaD
Levorphanol—Hyperhidrosis—Mitoxantrone—breast cancer	0.000203	0.00121	CcSEcCtD
Levorphanol—Hyperhidrosis—Irinotecan—breast cancer	0.000203	0.00121	CcSEcCtD
Levorphanol—Confusional state—Fluorouracil—breast cancer	0.000203	0.00121	CcSEcCtD
Levorphanol—Dizziness—Vinblastine—breast cancer	0.000203	0.00121	CcSEcCtD
Levorphanol—Urticaria—Vinorelbine—breast cancer	0.000203	0.00121	CcSEcCtD
Levorphanol—Muscle spasms—Paclitaxel—breast cancer	0.000202	0.0012	CcSEcCtD
Levorphanol—Mood swings—Methotrexate—breast cancer	0.000202	0.0012	CcSEcCtD
Levorphanol—Bradycardia—Capecitabine—breast cancer	0.000202	0.0012	CcSEcCtD
Levorphanol—Abdominal pain—Vinorelbine—breast cancer	0.000202	0.0012	CcSEcCtD
Levorphanol—Pruritus—Goserelin—breast cancer	0.000201	0.0012	CcSEcCtD
Levorphanol—Feeling abnormal—Thiotepa—breast cancer	0.000201	0.0012	CcSEcCtD
Levorphanol—Diplopia—Epirubicin—breast cancer	0.000199	0.00119	CcSEcCtD
Levorphanol—Gastrointestinal pain—Thiotepa—breast cancer	0.000199	0.00119	CcSEcCtD
Levorphanol—Nausea—Chlorambucil—breast cancer	0.000199	0.00118	CcSEcCtD
Levorphanol—Estradiol—ESR2—breast cancer	0.000199	0.0267	CrCbGaD
Levorphanol—Hyperhidrosis—Gemcitabine—breast cancer	0.000198	0.00118	CcSEcCtD
Levorphanol—Visual impairment—Docetaxel—breast cancer	0.000197	0.00117	CcSEcCtD
Levorphanol—Dizziness—Tamoxifen—breast cancer	0.000197	0.00117	CcSEcCtD
Levorphanol—Tachycardia—Fluorouracil—breast cancer	0.000197	0.00117	CcSEcCtD
Levorphanol—Hypotension—Irinotecan—breast cancer	0.000196	0.00117	CcSEcCtD
Levorphanol—Hypotension—Mitoxantrone—breast cancer	0.000196	0.00117	CcSEcCtD
Levorphanol—Affect lability—Epirubicin—breast cancer	0.000196	0.00117	CcSEcCtD
Levorphanol—Vomiting—Vinblastine—breast cancer	0.000195	0.00116	CcSEcCtD
Levorphanol—Urticaria—Thiotepa—breast cancer	0.000193	0.00115	CcSEcCtD
Levorphanol—Agitation—Paclitaxel—breast cancer	0.000193	0.00115	CcSEcCtD
Levorphanol—Abdominal pain—Thiotepa—breast cancer	0.000192	0.00115	CcSEcCtD
Levorphanol—Hypotension—Gemcitabine—breast cancer	0.000191	0.00114	CcSEcCtD
Levorphanol—Visual impairment—Capecitabine—breast cancer	0.000191	0.00114	CcSEcCtD
Levorphanol—Insomnia—Irinotecan—breast cancer	0.00019	0.00113	CcSEcCtD
Levorphanol—Flushing—Docetaxel—breast cancer	0.00019	0.00113	CcSEcCtD
Levorphanol—Cardiac arrest—Epirubicin—breast cancer	0.00019	0.00113	CcSEcCtD
Levorphanol—Vomiting—Tamoxifen—breast cancer	0.000189	0.00113	CcSEcCtD
Levorphanol—Dihydrocodeine—CYP3A4—breast cancer	0.000189	0.0254	CrCbGaD
Levorphanol—Mood swings—Epirubicin—breast cancer	0.000189	0.00113	CcSEcCtD
Levorphanol—Lethargy—Doxorubicin—breast cancer	0.000188	0.00112	CcSEcCtD
Levorphanol—Dizziness—Goserelin—breast cancer	0.000188	0.00112	CcSEcCtD
Levorphanol—Hypotension—Fluorouracil—breast cancer	0.000188	0.00112	CcSEcCtD
Levorphanol—Rash—Tamoxifen—breast cancer	0.000188	0.00112	CcSEcCtD
Levorphanol—Dermatitis—Tamoxifen—breast cancer	0.000188	0.00112	CcSEcCtD
Levorphanol—Palpitations—Paclitaxel—breast cancer	0.000186	0.00111	CcSEcCtD
Levorphanol—Vomiting—Melphalan—breast cancer	0.000186	0.00111	CcSEcCtD
Levorphanol—Insomnia—Gemcitabine—breast cancer	0.000185	0.0011	CcSEcCtD
Levorphanol—Dyspepsia—Mitoxantrone—breast cancer	0.000185	0.0011	CcSEcCtD
Levorphanol—Dyspepsia—Irinotecan—breast cancer	0.000185	0.0011	CcSEcCtD
Levorphanol—Diplopia—Doxorubicin—breast cancer	0.000185	0.0011	CcSEcCtD
Levorphanol—Rash—Melphalan—breast cancer	0.000184	0.0011	CcSEcCtD
Levorphanol—Flushing—Capecitabine—breast cancer	0.000184	0.0011	CcSEcCtD
Levorphanol—Dermatitis—Melphalan—breast cancer	0.000184	0.0011	CcSEcCtD
Levorphanol—Arrhythmia—Docetaxel—breast cancer	0.000183	0.00109	CcSEcCtD
Levorphanol—Nausea—Vinblastine—breast cancer	0.000182	0.00109	CcSEcCtD
Levorphanol—Insomnia—Fluorouracil—breast cancer	0.000182	0.00108	CcSEcCtD
Levorphanol—Convulsion—Paclitaxel—breast cancer	0.000182	0.00108	CcSEcCtD
Levorphanol—Affect lability—Doxorubicin—breast cancer	0.000182	0.00108	CcSEcCtD
Levorphanol—Estradiol—SHBG—breast cancer	0.000181	0.0243	CrCbGaD
Levorphanol—Estradiol—CYP1B1—breast cancer	0.000181	0.0243	CrCbGaD
Levorphanol—Vomiting—Goserelin—breast cancer	0.000181	0.00108	CcSEcCtD
Levorphanol—Pruritus—Vinorelbine—breast cancer	0.00018	0.00107	CcSEcCtD
Levorphanol—Constipation—Mitoxantrone—breast cancer	0.00018	0.00107	CcSEcCtD
Levorphanol—Constipation—Irinotecan—breast cancer	0.00018	0.00107	CcSEcCtD
Levorphanol—Rash—Goserelin—breast cancer	0.000179	0.00107	CcSEcCtD
Levorphanol—Dermatitis—Goserelin—breast cancer	0.000179	0.00107	CcSEcCtD
Levorphanol—Dyspepsia—Fluorouracil—breast cancer	0.000177	0.00106	CcSEcCtD
Levorphanol—Nausea—Tamoxifen—breast cancer	0.000177	0.00105	CcSEcCtD
Levorphanol—Arrhythmia—Capecitabine—breast cancer	0.000177	0.00105	CcSEcCtD
Levorphanol—Cardiac arrest—Doxorubicin—breast cancer	0.000175	0.00105	CcSEcCtD
Levorphanol—Constipation—Gemcitabine—breast cancer	0.000175	0.00104	CcSEcCtD
Levorphanol—Dry mouth—Paclitaxel—breast cancer	0.000175	0.00104	CcSEcCtD
Levorphanol—Mood swings—Doxorubicin—breast cancer	0.000175	0.00104	CcSEcCtD
Levorphanol—Nausea—Melphalan—breast cancer	0.000173	0.00103	CcSEcCtD
Levorphanol—Feeling abnormal—Irinotecan—breast cancer	0.000173	0.00103	CcSEcCtD
Levorphanol—Feeling abnormal—Mitoxantrone—breast cancer	0.000173	0.00103	CcSEcCtD
Levorphanol—Confusional state—Paclitaxel—breast cancer	0.000173	0.00103	CcSEcCtD
Levorphanol—Dysuria—Methotrexate—breast cancer	0.000172	0.00103	CcSEcCtD
Levorphanol—Pruritus—Thiotepa—breast cancer	0.000172	0.00103	CcSEcCtD
Levorphanol—Gastrointestinal pain—Mitoxantrone—breast cancer	0.000172	0.00102	CcSEcCtD
Levorphanol—Gastrointestinal pain—Irinotecan—breast cancer	0.000172	0.00102	CcSEcCtD
Levorphanol—Muscle spasms—Docetaxel—breast cancer	0.000171	0.00102	CcSEcCtD
Levorphanol—Hydrocodone—CYP2D6—breast cancer	0.000169	0.0227	CrCbGaD
Levorphanol—Nausea—Goserelin—breast cancer	0.000169	0.00101	CcSEcCtD
Levorphanol—Feeling abnormal—Gemcitabine—breast cancer	0.000169	0.00101	CcSEcCtD
Levorphanol—Shock—Paclitaxel—breast cancer	0.000169	0.001	CcSEcCtD
Levorphanol—Dizziness—Vinorelbine—breast cancer	0.000169	0.001	CcSEcCtD
Levorphanol—Tachycardia—Paclitaxel—breast cancer	0.000167	0.000997	CcSEcCtD
Levorphanol—Urticaria—Mitoxantrone—breast cancer	0.000167	0.000995	CcSEcCtD
Levorphanol—Abdominal pain—Mitoxantrone—breast cancer	0.000166	0.00099	CcSEcCtD
Levorphanol—Abdominal pain—Irinotecan—breast cancer	0.000166	0.00099	CcSEcCtD
Levorphanol—Feeling abnormal—Fluorouracil—breast cancer	0.000166	0.000989	CcSEcCtD
Levorphanol—Muscle spasms—Capecitabine—breast cancer	0.000166	0.000987	CcSEcCtD
Levorphanol—Hyperhidrosis—Paclitaxel—breast cancer	0.000166	0.000987	CcSEcCtD
Levorphanol—Estrone—ABCG2—breast cancer	0.000165	0.0221	CrCbGaD
Levorphanol—Vomiting—Vinorelbine—breast cancer	0.000162	0.000966	CcSEcCtD
Levorphanol—Estrone—ESR1—breast cancer	0.000161	0.0217	CrCbGaD
Levorphanol—Renal failure—Methotrexate—breast cancer	0.000161	0.000962	CcSEcCtD
Levorphanol—Dysuria—Epirubicin—breast cancer	0.000161	0.00096	CcSEcCtD
Levorphanol—Dizziness—Thiotepa—breast cancer	0.000161	0.000959	CcSEcCtD
Levorphanol—Rash—Vinorelbine—breast cancer	0.000161	0.000958	CcSEcCtD
Levorphanol—Dermatitis—Vinorelbine—breast cancer	0.000161	0.000957	CcSEcCtD
Levorphanol—Hypotension—Paclitaxel—breast cancer	0.00016	0.000954	CcSEcCtD
Levorphanol—Urticaria—Fluorouracil—breast cancer	0.00016	0.000953	CcSEcCtD
Levorphanol—Estradiol—AR—breast cancer	0.000159	0.0213	CrCbGaD
Levorphanol—Sweating—Methotrexate—breast cancer	0.000157	0.000938	CcSEcCtD
Levorphanol—Palpitations—Docetaxel—breast cancer	0.000157	0.000937	CcSEcCtD
Levorphanol—Insomnia—Paclitaxel—breast cancer	0.000155	0.000924	CcSEcCtD
Levorphanol—Vomiting—Thiotepa—breast cancer	0.000155	0.000922	CcSEcCtD
Levorphanol—Convulsion—Docetaxel—breast cancer	0.000154	0.000919	CcSEcCtD
Levorphanol—Rash—Thiotepa—breast cancer	0.000154	0.000914	CcSEcCtD
Levorphanol—Dermatitis—Thiotepa—breast cancer	0.000153	0.000914	CcSEcCtD
Levorphanol—Palpitations—Capecitabine—breast cancer	0.000152	0.000908	CcSEcCtD
Levorphanol—Nausea—Vinorelbine—breast cancer	0.000151	0.000902	CcSEcCtD
Levorphanol—Renal failure—Epirubicin—breast cancer	0.000151	0.0009	CcSEcCtD
Levorphanol—Dyspepsia—Paclitaxel—breast cancer	0.000151	0.000899	CcSEcCtD
Levorphanol—Dysuria—Doxorubicin—breast cancer	0.000149	0.000889	CcSEcCtD
Levorphanol—Dry mouth—Docetaxel—breast cancer	0.000148	0.000883	CcSEcCtD
Levorphanol—Sweating—Epirubicin—breast cancer	0.000147	0.000878	CcSEcCtD
Levorphanol—Constipation—Paclitaxel—breast cancer	0.000147	0.000874	CcSEcCtD
Levorphanol—Confusional state—Docetaxel—breast cancer	0.000147	0.000873	CcSEcCtD
Levorphanol—Hydrocodone—CYP3A4—breast cancer	0.000145	0.0195	CrCbGaD
Levorphanol—Pruritus—Gemcitabine—breast cancer	0.000145	0.000863	CcSEcCtD
Levorphanol—Nausea—Thiotepa—breast cancer	0.000145	0.000861	CcSEcCtD
Levorphanol—Dry mouth—Capecitabine—breast cancer	0.000144	0.000855	CcSEcCtD
Levorphanol—Shock—Docetaxel—breast cancer	0.000143	0.000852	CcSEcCtD
Levorphanol—Pruritus—Fluorouracil—breast cancer	0.000142	0.000849	CcSEcCtD
Levorphanol—Visual impairment—Methotrexate—breast cancer	0.000142	0.000846	CcSEcCtD
Levorphanol—Confusional state—Capecitabine—breast cancer	0.000142	0.000845	CcSEcCtD
Levorphanol—Tachycardia—Docetaxel—breast cancer	0.000142	0.000845	CcSEcCtD
Levorphanol—Feeling abnormal—Paclitaxel—breast cancer	0.000141	0.000842	CcSEcCtD
Levorphanol—Bradycardia—Epirubicin—breast cancer	0.00014	0.000837	CcSEcCtD
Levorphanol—Gastrointestinal pain—Paclitaxel—breast cancer	0.00014	0.000835	CcSEcCtD
Levorphanol—Hydromorphone—CYP2D6—breast cancer	0.00014	0.0188	CrCbGaD
Levorphanol—Renal failure—Doxorubicin—breast cancer	0.00014	0.000833	CcSEcCtD
Levorphanol—Dizziness—Irinotecan—breast cancer	0.000139	0.000828	CcSEcCtD
Levorphanol—Shock—Capecitabine—breast cancer	0.000138	0.000825	CcSEcCtD
Levorphanol—Tachycardia—Capecitabine—breast cancer	0.000137	0.000818	CcSEcCtD
Levorphanol—Sweating—Doxorubicin—breast cancer	0.000136	0.000812	CcSEcCtD
Levorphanol—Urticaria—Paclitaxel—breast cancer	0.000136	0.000811	CcSEcCtD
Levorphanol—Hyperhidrosis—Capecitabine—breast cancer	0.000136	0.00081	CcSEcCtD
Levorphanol—Hypotension—Docetaxel—breast cancer	0.000136	0.000809	CcSEcCtD
Levorphanol—Abdominal pain—Paclitaxel—breast cancer	0.000136	0.000807	CcSEcCtD
Levorphanol—Vomiting—Irinotecan—breast cancer	0.000134	0.000796	CcSEcCtD
Levorphanol—Vomiting—Mitoxantrone—breast cancer	0.000134	0.000796	CcSEcCtD
Levorphanol—Dizziness—Fluorouracil—breast cancer	0.000133	0.000793	CcSEcCtD
Levorphanol—Visual impairment—Epirubicin—breast cancer	0.000133	0.000792	CcSEcCtD
Levorphanol—Rash—Mitoxantrone—breast cancer	0.000133	0.00079	CcSEcCtD
Levorphanol—Rash—Irinotecan—breast cancer	0.000133	0.00079	CcSEcCtD
Levorphanol—Dermatitis—Mitoxantrone—breast cancer	0.000132	0.000789	CcSEcCtD
Levorphanol—Dermatitis—Irinotecan—breast cancer	0.000132	0.000789	CcSEcCtD
Levorphanol—Hypotension—Capecitabine—breast cancer	0.000131	0.000783	CcSEcCtD
Levorphanol—Insomnia—Docetaxel—breast cancer	0.000131	0.000783	CcSEcCtD
Levorphanol—Vomiting—Gemcitabine—breast cancer	0.00013	0.000776	CcSEcCtD
Levorphanol—Bradycardia—Doxorubicin—breast cancer	0.00013	0.000774	CcSEcCtD
Levorphanol—Rash—Gemcitabine—breast cancer	0.000129	0.000769	CcSEcCtD
Levorphanol—Estrone—CYP1A1—breast cancer	0.000129	0.0173	CrCbGaD
Levorphanol—Dermatitis—Gemcitabine—breast cancer	0.000129	0.000769	CcSEcCtD
Levorphanol—Flushing—Epirubicin—breast cancer	0.000128	0.000763	CcSEcCtD
Levorphanol—Vomiting—Fluorouracil—breast cancer	0.000128	0.000763	CcSEcCtD
Levorphanol—Dyspepsia—Docetaxel—breast cancer	0.000128	0.000762	CcSEcCtD
Levorphanol—Insomnia—Capecitabine—breast cancer	0.000127	0.000758	CcSEcCtD
Levorphanol—Rash—Fluorouracil—breast cancer	0.000127	0.000756	CcSEcCtD
Levorphanol—Dermatitis—Fluorouracil—breast cancer	0.000127	0.000756	CcSEcCtD
Levorphanol—Estradiol—ABCG2—breast cancer	0.000125	0.0168	CrCbGaD
Levorphanol—Nausea—Mitoxantrone—breast cancer	0.000125	0.000744	CcSEcCtD
Levorphanol—Nausea—Irinotecan—breast cancer	0.000125	0.000744	CcSEcCtD
Levorphanol—Constipation—Docetaxel—breast cancer	0.000124	0.00074	CcSEcCtD
Levorphanol—Dyspepsia—Capecitabine—breast cancer	0.000124	0.000738	CcSEcCtD
Levorphanol—Arrhythmia—Epirubicin—breast cancer	0.000123	0.000734	CcSEcCtD
Levorphanol—Visual impairment—Doxorubicin—breast cancer	0.000123	0.000733	CcSEcCtD
Levorphanol—Estradiol—ESR1—breast cancer	0.000122	0.0164	CrCbGaD
Levorphanol—Nausea—Gemcitabine—breast cancer	0.000122	0.000725	CcSEcCtD
Levorphanol—Pruritus—Paclitaxel—breast cancer	0.000121	0.000723	CcSEcCtD
Levorphanol—Constipation—Capecitabine—breast cancer	0.00012	0.000717	CcSEcCtD
Levorphanol—Hydromorphone—CYP3A4—breast cancer	0.00012	0.0161	CrCbGaD
Levorphanol—Feeling abnormal—Docetaxel—breast cancer	0.00012	0.000713	CcSEcCtD
Levorphanol—Nausea—Fluorouracil—breast cancer	0.00012	0.000713	CcSEcCtD
Levorphanol—Morphine—CYP2D6—breast cancer	0.000119	0.016	CrCbGaD
Levorphanol—Gastrointestinal pain—Docetaxel—breast cancer	0.000119	0.000708	CcSEcCtD
Levorphanol—Flushing—Doxorubicin—breast cancer	0.000118	0.000706	CcSEcCtD
Levorphanol—Tension—Epirubicin—breast cancer	0.000118	0.000702	CcSEcCtD
Levorphanol—Nervousness—Epirubicin—breast cancer	0.000117	0.000695	CcSEcCtD
Levorphanol—Feeling abnormal—Capecitabine—breast cancer	0.000116	0.000691	CcSEcCtD
Levorphanol—Muscle spasms—Epirubicin—breast cancer	0.000115	0.000688	CcSEcCtD
Levorphanol—Gastrointestinal pain—Capecitabine—breast cancer	0.000115	0.000685	CcSEcCtD
Levorphanol—Abdominal pain—Docetaxel—breast cancer	0.000115	0.000684	CcSEcCtD
Levorphanol—Arrhythmia—Doxorubicin—breast cancer	0.000114	0.000679	CcSEcCtD
Levorphanol—Dizziness—Paclitaxel—breast cancer	0.000113	0.000675	CcSEcCtD
Levorphanol—Urticaria—Capecitabine—breast cancer	0.000112	0.000666	CcSEcCtD
Levorphanol—Abdominal pain—Capecitabine—breast cancer	0.000111	0.000663	CcSEcCtD
Levorphanol—Convulsion—Methotrexate—breast cancer	0.000111	0.000662	CcSEcCtD
Levorphanol—Agitation—Epirubicin—breast cancer	0.00011	0.000658	CcSEcCtD
Levorphanol—Tension—Doxorubicin—breast cancer	0.000109	0.00065	CcSEcCtD
Levorphanol—Vomiting—Paclitaxel—breast cancer	0.000109	0.000649	CcSEcCtD
Levorphanol—Rash—Paclitaxel—breast cancer	0.000108	0.000644	CcSEcCtD
Levorphanol—Dermatitis—Paclitaxel—breast cancer	0.000108	0.000643	CcSEcCtD
Levorphanol—Nervousness—Doxorubicin—breast cancer	0.000108	0.000643	CcSEcCtD
Levorphanol—Muscle spasms—Doxorubicin—breast cancer	0.000107	0.000637	CcSEcCtD
Levorphanol—Palpitations—Epirubicin—breast cancer	0.000106	0.000632	CcSEcCtD
Levorphanol—Confusional state—Methotrexate—breast cancer	0.000106	0.000629	CcSEcCtD
Levorphanol—Convulsion—Epirubicin—breast cancer	0.000104	0.00062	CcSEcCtD
Levorphanol—Pruritus—Docetaxel—breast cancer	0.000103	0.000613	CcSEcCtD
Levorphanol—Morphine—CYP3A4—breast cancer	0.000102	0.0137	CrCbGaD
Levorphanol—Agitation—Doxorubicin—breast cancer	0.000102	0.000608	CcSEcCtD
Levorphanol—Nausea—Paclitaxel—breast cancer	0.000102	0.000607	CcSEcCtD
Levorphanol—Hyperhidrosis—Methotrexate—breast cancer	0.000101	0.000603	CcSEcCtD
Levorphanol—Dextromethorphan—CYP2D6—breast cancer	0.0001	0.0134	CrCbGaD
Levorphanol—Dry mouth—Epirubicin—breast cancer	0.0001	0.000596	CcSEcCtD
Levorphanol—Pruritus—Capecitabine—breast cancer	9.96e-05	0.000593	CcSEcCtD
Levorphanol—Confusional state—Epirubicin—breast cancer	9.88e-05	0.000589	CcSEcCtD
Levorphanol—Palpitations—Doxorubicin—breast cancer	9.82e-05	0.000585	CcSEcCtD
Levorphanol—Hypotension—Methotrexate—breast cancer	9.79e-05	0.000583	CcSEcCtD
Levorphanol—Estradiol—CYP1A1—breast cancer	9.78e-05	0.0131	CrCbGaD
Levorphanol—Shock—Epirubicin—breast cancer	9.64e-05	0.000575	CcSEcCtD
Levorphanol—Convulsion—Doxorubicin—breast cancer	9.63e-05	0.000574	CcSEcCtD
Levorphanol—Dizziness—Docetaxel—breast cancer	9.61e-05	0.000573	CcSEcCtD
Levorphanol—Tachycardia—Epirubicin—breast cancer	9.57e-05	0.00057	CcSEcCtD
Levorphanol—Hyperhidrosis—Epirubicin—breast cancer	9.48e-05	0.000565	CcSEcCtD
Levorphanol—Insomnia—Methotrexate—breast cancer	9.47e-05	0.000564	CcSEcCtD
Levorphanol—Dizziness—Capecitabine—breast cancer	9.3e-05	0.000554	CcSEcCtD
Levorphanol—Dry mouth—Doxorubicin—breast cancer	9.25e-05	0.000551	CcSEcCtD
Levorphanol—Vomiting—Docetaxel—breast cancer	9.24e-05	0.00055	CcSEcCtD
Levorphanol—Dyspepsia—Methotrexate—breast cancer	9.22e-05	0.000549	CcSEcCtD
Levorphanol—Rash—Docetaxel—breast cancer	9.16e-05	0.000546	CcSEcCtD
Levorphanol—Hypotension—Epirubicin—breast cancer	9.16e-05	0.000546	CcSEcCtD
Levorphanol—Dermatitis—Docetaxel—breast cancer	9.16e-05	0.000545	CcSEcCtD
Levorphanol—Confusional state—Doxorubicin—breast cancer	9.15e-05	0.000545	CcSEcCtD
Levorphanol—Vomiting—Capecitabine—breast cancer	8.95e-05	0.000533	CcSEcCtD
Levorphanol—Shock—Doxorubicin—breast cancer	8.92e-05	0.000532	CcSEcCtD
Levorphanol—Rash—Capecitabine—breast cancer	8.87e-05	0.000529	CcSEcCtD
Levorphanol—Insomnia—Epirubicin—breast cancer	8.87e-05	0.000528	CcSEcCtD
Levorphanol—Dermatitis—Capecitabine—breast cancer	8.86e-05	0.000528	CcSEcCtD
Levorphanol—Tachycardia—Doxorubicin—breast cancer	8.85e-05	0.000527	CcSEcCtD
Levorphanol—Hyperhidrosis—Doxorubicin—breast cancer	8.77e-05	0.000522	CcSEcCtD
Levorphanol—Nausea—Docetaxel—breast cancer	8.63e-05	0.000514	CcSEcCtD
Levorphanol—Feeling abnormal—Methotrexate—breast cancer	8.63e-05	0.000514	CcSEcCtD
Levorphanol—Dyspepsia—Epirubicin—breast cancer	8.63e-05	0.000514	CcSEcCtD
Levorphanol—Dextromethorphan—CYP3A4—breast cancer	8.58e-05	0.0115	CrCbGaD
Levorphanol—Gastrointestinal pain—Methotrexate—breast cancer	8.57e-05	0.00051	CcSEcCtD
Levorphanol—Morphine—ABCB1—breast cancer	8.51e-05	0.0114	CrCbGaD
Levorphanol—Hypotension—Doxorubicin—breast cancer	8.48e-05	0.000505	CcSEcCtD
Levorphanol—Constipation—Epirubicin—breast cancer	8.38e-05	0.000499	CcSEcCtD
Levorphanol—Nausea—Capecitabine—breast cancer	8.36e-05	0.000498	CcSEcCtD
Levorphanol—Urticaria—Methotrexate—breast cancer	8.32e-05	0.000496	CcSEcCtD
Levorphanol—Abdominal pain—Methotrexate—breast cancer	8.28e-05	0.000493	CcSEcCtD
Levorphanol—Estrone—CYP3A4—breast cancer	8.24e-05	0.0111	CrCbGaD
Levorphanol—Insomnia—Doxorubicin—breast cancer	8.2e-05	0.000489	CcSEcCtD
Levorphanol—Feeling abnormal—Epirubicin—breast cancer	8.08e-05	0.000481	CcSEcCtD
Levorphanol—Gastrointestinal pain—Epirubicin—breast cancer	8.02e-05	0.000478	CcSEcCtD
Levorphanol—Dyspepsia—Doxorubicin—breast cancer	7.98e-05	0.000476	CcSEcCtD
Levorphanol—Urticaria—Epirubicin—breast cancer	7.79e-05	0.000464	CcSEcCtD
Levorphanol—Constipation—Doxorubicin—breast cancer	7.76e-05	0.000462	CcSEcCtD
Levorphanol—Abdominal pain—Epirubicin—breast cancer	7.75e-05	0.000462	CcSEcCtD
Levorphanol—Feeling abnormal—Doxorubicin—breast cancer	7.47e-05	0.000445	CcSEcCtD
Levorphanol—Gastrointestinal pain—Doxorubicin—breast cancer	7.42e-05	0.000442	CcSEcCtD
Levorphanol—Pruritus—Methotrexate—breast cancer	7.41e-05	0.000441	CcSEcCtD
Levorphanol—Urticaria—Doxorubicin—breast cancer	7.21e-05	0.000429	CcSEcCtD
Levorphanol—Estrone—ALB—breast cancer	7.19e-05	0.00965	CrCbGaD
Levorphanol—Abdominal pain—Doxorubicin—breast cancer	7.17e-05	0.000427	CcSEcCtD
Levorphanol—Dextromethorphan—ABCB1—breast cancer	7.15e-05	0.00959	CrCbGaD
Levorphanol—Pruritus—Epirubicin—breast cancer	6.94e-05	0.000413	CcSEcCtD
Levorphanol—Dizziness—Methotrexate—breast cancer	6.93e-05	0.000413	CcSEcCtD
Levorphanol—Estrone—ABCB1—breast cancer	6.86e-05	0.00921	CrCbGaD
Levorphanol—Vomiting—Methotrexate—breast cancer	6.66e-05	0.000397	CcSEcCtD
Levorphanol—Rash—Methotrexate—breast cancer	6.6e-05	0.000393	CcSEcCtD
Levorphanol—Dermatitis—Methotrexate—breast cancer	6.6e-05	0.000393	CcSEcCtD
Levorphanol—Dizziness—Epirubicin—breast cancer	6.48e-05	0.000386	CcSEcCtD
Levorphanol—Pruritus—Doxorubicin—breast cancer	6.42e-05	0.000382	CcSEcCtD
Levorphanol—Estradiol—CYP3A4—breast cancer	6.24e-05	0.00838	CrCbGaD
Levorphanol—Vomiting—Epirubicin—breast cancer	6.23e-05	0.000371	CcSEcCtD
Levorphanol—Nausea—Methotrexate—breast cancer	6.22e-05	0.000371	CcSEcCtD
Levorphanol—Rash—Epirubicin—breast cancer	6.18e-05	0.000368	CcSEcCtD
Levorphanol—Dermatitis—Epirubicin—breast cancer	6.18e-05	0.000368	CcSEcCtD
Levorphanol—Dizziness—Doxorubicin—breast cancer	6e-05	0.000357	CcSEcCtD
Levorphanol—Nausea—Epirubicin—breast cancer	5.82e-05	0.000347	CcSEcCtD
Levorphanol—Vomiting—Doxorubicin—breast cancer	5.77e-05	0.000344	CcSEcCtD
Levorphanol—Rash—Doxorubicin—breast cancer	5.72e-05	0.000341	CcSEcCtD
Levorphanol—Dermatitis—Doxorubicin—breast cancer	5.71e-05	0.00034	CcSEcCtD
Levorphanol—Estradiol—ALB—breast cancer	5.45e-05	0.00731	CrCbGaD
Levorphanol—Nausea—Doxorubicin—breast cancer	5.39e-05	0.000321	CcSEcCtD
Levorphanol—Estradiol—ABCB1—breast cancer	5.2e-05	0.00698	CrCbGaD
Levorphanol—OPRD1—Signaling Pathways—E2F1—breast cancer	1.71e-05	0.000299	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—PIK3CB—breast cancer	1.71e-05	0.000297	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PAK1—breast cancer	1.7e-05	0.000296	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—TGFBR2—breast cancer	1.69e-05	0.000295	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—TCF7L2—breast cancer	1.67e-05	0.000291	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—ITPR1—breast cancer	1.66e-05	0.00029	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—AKT2—breast cancer	1.66e-05	0.00029	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—STAT5A—breast cancer	1.65e-05	0.000288	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—ERBB4—breast cancer	1.65e-05	0.000288	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—MMP3—breast cancer	1.65e-05	0.000288	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—PIK3CG—breast cancer	1.65e-05	0.000288	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—PIK3CB—breast cancer	1.65e-05	0.000287	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—SPP1—breast cancer	1.65e-05	0.000287	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—CXCL8—breast cancer	1.64e-05	0.000286	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—ERBB3—breast cancer	1.63e-05	0.000284	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—FGFR2—breast cancer	1.63e-05	0.000284	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—HSP90AA1—breast cancer	1.61e-05	0.000281	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—NOTCH2—breast cancer	1.61e-05	0.000281	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—SMAD4—breast cancer	1.6e-05	0.000279	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—PIK3CD—breast cancer	1.6e-05	0.000278	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—IGF1R—breast cancer	1.59e-05	0.000277	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—CXCL8—breast cancer	1.58e-05	0.000276	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—IL2—breast cancer	1.57e-05	0.000273	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—AGTR1—breast cancer	1.57e-05	0.000273	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PRL—breast cancer	1.57e-05	0.000273	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—HES1—breast cancer	1.56e-05	0.000272	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—TERT—breast cancer	1.56e-05	0.000272	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—NCOR1—breast cancer	1.55e-05	0.000271	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PLA2G4A—breast cancer	1.55e-05	0.000271	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—ADAM10—breast cancer	1.54e-05	0.000269	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—STK11—breast cancer	1.54e-05	0.000269	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CSF2—breast cancer	1.54e-05	0.000268	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—FGF1—breast cancer	1.54e-05	0.000268	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—RAF1—breast cancer	1.53e-05	0.000267	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PLG—breast cancer	1.53e-05	0.000266	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—NRG1—breast cancer	1.52e-05	0.000266	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—FGFR1—breast cancer	1.52e-05	0.000264	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—H2AFX—breast cancer	1.51e-05	0.000264	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—IL2—breast cancer	1.51e-05	0.000264	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—AKT2—breast cancer	1.51e-05	0.000263	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—E2F1—breast cancer	1.5e-05	0.000262	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—FGF10—breast cancer	1.5e-05	0.000262	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—PIK3CB—breast cancer	1.5e-05	0.000261	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—HIF1A—breast cancer	1.49e-05	0.00026	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—LEP—breast cancer	1.46e-05	0.000254	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—PIK3CD—breast cancer	1.45e-05	0.000253	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PDGFA—breast cancer	1.45e-05	0.000253	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CAV1—breast cancer	1.44e-05	0.000252	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—SPP1—breast cancer	1.44e-05	0.000252	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—CXCL8—breast cancer	1.44e-05	0.000251	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—TGFBR2—breast cancer	1.43e-05	0.000249	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—ERBB3—breast cancer	1.43e-05	0.000249	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—KDR—breast cancer	1.43e-05	0.000249	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—FGFR2—breast cancer	1.43e-05	0.000249	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—ITPR1—breast cancer	1.41e-05	0.000245	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—STAT5A—breast cancer	1.4e-05	0.000243	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MMP3—breast cancer	1.4e-05	0.000243	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—ERBB4—breast cancer	1.4e-05	0.000243	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—PIK3CB—breast cancer	1.39e-05	0.000243	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—ESR1—breast cancer	1.39e-05	0.000243	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—FN1—breast cancer	1.37e-05	0.00024	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—IL2—breast cancer	1.37e-05	0.00024	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—TERT—breast cancer	1.37e-05	0.000239	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—NFKBIA—breast cancer	1.36e-05	0.000237	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—SMAD4—breast cancer	1.35e-05	0.000236	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—NOTCH1—breast cancer	1.34e-05	0.000234	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—IGF1R—breast cancer	1.34e-05	0.000234	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—CXCL8—breast cancer	1.34e-05	0.000233	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—FGFR1—breast cancer	1.33e-05	0.000232	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—HES1—breast cancer	1.32e-05	0.00023	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—APC—breast cancer	1.31e-05	0.000229	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PIK3CG—breast cancer	1.31e-05	0.000229	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—KIT—breast cancer	1.31e-05	0.000229	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PLA2G4A—breast cancer	1.31e-05	0.000229	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—NCOR1—breast cancer	1.31e-05	0.000229	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—HIF1A—breast cancer	1.31e-05	0.000228	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—EGF—breast cancer	1.3e-05	0.000227	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CSF2—breast cancer	1.3e-05	0.000226	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—FGF1—breast cancer	1.3e-05	0.000226	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—RAF1—breast cancer	1.29e-05	0.000226	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—NRG1—breast cancer	1.29e-05	0.000225	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—H2AFX—breast cancer	1.28e-05	0.000223	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—IL2—breast cancer	1.28e-05	0.000223	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—LEP—breast cancer	1.28e-05	0.000223	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—E2F1—breast cancer	1.27e-05	0.000221	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CAV1—breast cancer	1.27e-05	0.000221	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—PIK3CB—breast cancer	1.26e-05	0.00022	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—MAPK3—breast cancer	1.26e-05	0.00022	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—KDR—breast cancer	1.25e-05	0.000218	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—BRAF—breast cancer	1.24e-05	0.000216	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—SPP1—breast cancer	1.22e-05	0.000213	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—ESR1—breast cancer	1.22e-05	0.000213	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—CXCL8—breast cancer	1.21e-05	0.000212	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—ERBB3—breast cancer	1.21e-05	0.00021	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—FGFR2—breast cancer	1.2e-05	0.00021	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—FN1—breast cancer	1.2e-05	0.00021	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—IGF1—breast cancer	1.2e-05	0.00021	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—AKT2—breast cancer	1.2e-05	0.00021	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—EGFR—breast cancer	1.2e-05	0.000209	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—NFKBIA—breast cancer	1.19e-05	0.000208	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—NOTCH1—breast cancer	1.18e-05	0.000206	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—IL2—breast cancer	1.16e-05	0.000202	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—TERT—breast cancer	1.16e-05	0.000202	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PIK3CD—breast cancer	1.16e-05	0.000202	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PIK3CG—breast cancer	1.15e-05	0.000201	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—APC—breast cancer	1.15e-05	0.000201	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—KIT—breast cancer	1.15e-05	0.000201	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—PIK3CA—breast cancer	1.14e-05	0.0002	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—SERPINE1—breast cancer	1.14e-05	0.000199	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—EGF—breast cancer	1.14e-05	0.000199	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—KRAS—breast cancer	1.13e-05	0.000197	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—FGFR1—breast cancer	1.12e-05	0.000196	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—HIF1A—breast cancer	1.11e-05	0.000193	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—MAPK3—breast cancer	1.1e-05	0.000193	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—NOS3—breast cancer	1.09e-05	0.00019	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—BRAF—breast cancer	1.08e-05	0.000189	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—LEP—breast cancer	1.08e-05	0.000188	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CAV1—breast cancer	1.07e-05	0.000187	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—KDR—breast cancer	1.06e-05	0.000184	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—IGF1—breast cancer	1.06e-05	0.000184	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—AKT2—breast cancer	1.05e-05	0.000184	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—EGFR—breast cancer	1.05e-05	0.000183	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—PIK3CA—breast cancer	1.04e-05	0.000181	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—MDM2—breast cancer	1.04e-05	0.000181	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—RAF1—breast cancer	1.03e-05	0.00018	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—ESR1—breast cancer	1.03e-05	0.00018	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—RELA—breast cancer	1.03e-05	0.000179	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—ERBB2—breast cancer	1.02e-05	0.000178	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—FN1—breast cancer	1.02e-05	0.000178	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PIK3CD—breast cancer	1.01e-05	0.000177	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—MTOR—breast cancer	1.01e-05	0.000176	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PIK3CB—breast cancer	1.01e-05	0.000176	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—NFKBIA—breast cancer	1.01e-05	0.000175	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—PIK3CA—breast cancer	1e-05	0.000175	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—SERPINE1—breast cancer	1e-05	0.000175	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—NOTCH1—breast cancer	9.97e-06	0.000174	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—KRAS—breast cancer	9.92e-06	0.000173	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PIK3CG—breast cancer	9.74e-06	0.00017	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—KIT—breast cancer	9.74e-06	0.00017	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—APC—breast cancer	9.74e-06	0.00017	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CXCL8—breast cancer	9.68e-06	0.000169	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—EGF—breast cancer	9.63e-06	0.000168	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—HRAS—breast cancer	9.62e-06	0.000168	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—NOS3—breast cancer	9.57e-06	0.000167	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CDKN1B—breast cancer	9.46e-06	0.000165	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—AKT1—breast cancer	9.35e-06	0.000163	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—MAPK3—breast cancer	9.33e-06	0.000163	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CASP3—breast cancer	9.27e-06	0.000162	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—IL2—breast cancer	9.25e-06	0.000161	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—IL6—breast cancer	9.21e-06	0.000161	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—BRAF—breast cancer	9.16e-06	0.00016	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—PIK3CA—breast cancer	9.12e-06	0.000159	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—MDM2—breast cancer	9.08e-06	0.000158	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—RAF1—breast cancer	9.05e-06	0.000158	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CCND1—breast cancer	9.02e-06	0.000157	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—RELA—breast cancer	9.01e-06	0.000157	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—JUN—breast cancer	9e-06	0.000157	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—ERBB2—breast cancer	8.95e-06	0.000156	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CTNNB1—breast cancer	8.93e-06	0.000156	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—IGF1—breast cancer	8.92e-06	0.000156	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—AKT2—breast cancer	8.92e-06	0.000155	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—EGFR—breast cancer	8.88e-06	0.000155	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PIK3CB—breast cancer	8.84e-06	0.000154	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—MTOR—breast cancer	8.84e-06	0.000154	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—MMP9—breast cancer	8.76e-06	0.000153	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CDKN1A—breast cancer	8.73e-06	0.000152	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PTEN—breast cancer	8.71e-06	0.000152	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PIK3CD—breast cancer	8.57e-06	0.000149	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—MAPK8—breast cancer	8.52e-06	0.000149	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—AKT1—breast cancer	8.49e-06	0.000148	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CXCL8—breast cancer	8.49e-06	0.000148	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—PIK3CA—breast cancer	8.49e-06	0.000148	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—SERPINE1—breast cancer	8.47e-06	0.000148	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—HRAS—breast cancer	8.44e-06	0.000147	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—KRAS—breast cancer	8.39e-06	0.000146	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CDKN1B—breast cancer	8.29e-06	0.000145	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—AKT1—breast cancer	8.2e-06	0.000143	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CASP3—breast cancer	8.13e-06	0.000142	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—IL2—breast cancer	8.11e-06	0.000141	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—NOS3—breast cancer	8.09e-06	0.000141	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—SRC—breast cancer	8.07e-06	0.000141	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—IL6—breast cancer	8.07e-06	0.000141	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CCND1—breast cancer	7.91e-06	0.000138	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—JUN—breast cancer	7.89e-06	0.000138	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—VEGFA—breast cancer	7.86e-06	0.000137	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CTNNB1—breast cancer	7.83e-06	0.000137	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—STAT3—breast cancer	7.79e-06	0.000136	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—PIK3CA—breast cancer	7.71e-06	0.000134	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—MMP9—breast cancer	7.68e-06	0.000134	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MDM2—breast cancer	7.67e-06	0.000134	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CDKN1A—breast cancer	7.65e-06	0.000133	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—RAF1—breast cancer	7.65e-06	0.000133	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PTEN—breast cancer	7.63e-06	0.000133	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—RELA—breast cancer	7.61e-06	0.000133	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—ERBB2—breast cancer	7.57e-06	0.000132	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—MAPK8—breast cancer	7.47e-06	0.00013	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MTOR—breast cancer	7.47e-06	0.00013	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PIK3CB—breast cancer	7.47e-06	0.00013	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—AKT1—breast cancer	7.45e-06	0.00013	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—MAPK3—breast cancer	7.44e-06	0.00013	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—MYC—breast cancer	7.24e-06	0.000126	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—TGFB1—breast cancer	7.22e-06	0.000126	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CXCL8—breast cancer	7.18e-06	0.000125	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—HRAS—breast cancer	7.13e-06	0.000124	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—SRC—breast cancer	7.08e-06	0.000123	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—EGFR—breast cancer	7.08e-06	0.000123	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CDKN1B—breast cancer	7.01e-06	0.000122	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—AKT1—breast cancer	6.93e-06	0.000121	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—VEGFA—breast cancer	6.9e-06	0.00012	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CASP3—breast cancer	6.87e-06	0.00012	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—IL2—breast cancer	6.86e-06	0.00012	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—STAT3—breast cancer	6.83e-06	0.000119	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—IL6—breast cancer	6.82e-06	0.000119	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—KRAS—breast cancer	6.69e-06	0.000117	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CCND1—breast cancer	6.69e-06	0.000117	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—JUN—breast cancer	6.67e-06	0.000116	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CTNNB1—breast cancer	6.62e-06	0.000115	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—MAPK3—breast cancer	6.52e-06	0.000114	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MMP9—breast cancer	6.49e-06	0.000113	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CDKN1A—breast cancer	6.47e-06	0.000113	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PTEN—breast cancer	6.45e-06	0.000113	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—MYC—breast cancer	6.34e-06	0.000111	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—TGFB1—breast cancer	6.33e-06	0.00011	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MAPK8—breast cancer	6.31e-06	0.00011	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—AKT1—breast cancer	6.29e-06	0.00011	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—EGFR—breast cancer	6.21e-06	0.000108	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PIK3CA—breast cancer	6.14e-06	0.000107	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—SRC—breast cancer	5.98e-06	0.000104	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—TP53—breast cancer	5.94e-06	0.000104	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—KRAS—breast cancer	5.86e-06	0.000102	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—VEGFA—breast cancer	5.83e-06	0.000102	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—STAT3—breast cancer	5.77e-06	0.000101	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—HRAS—breast cancer	5.68e-06	9.91e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MAPK3—breast cancer	5.51e-06	9.61e-05	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—IL6—breast cancer	5.44e-06	9.48e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PIK3CA—breast cancer	5.39e-06	9.39e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MYC—breast cancer	5.36e-06	9.35e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—TGFB1—breast cancer	5.35e-06	9.33e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—EGFR—breast cancer	5.24e-06	9.15e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—TP53—breast cancer	5.21e-06	9.09e-05	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—AKT1—breast cancer	5.02e-06	8.75e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—HRAS—breast cancer	4.98e-06	8.69e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—KRAS—breast cancer	4.95e-06	8.64e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—IL6—breast cancer	4.77e-06	8.32e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PIK3CA—breast cancer	4.55e-06	7.94e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—TP53—breast cancer	4.4e-06	7.68e-05	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—AKT1—breast cancer	4.4e-06	7.67e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—HRAS—breast cancer	4.21e-06	7.34e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—IL6—breast cancer	4.03e-06	7.03e-05	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—AKT1—breast cancer	3.72e-06	6.48e-05	CbGpPWpGaD
